GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 114 filers reported holding GOSSAMER BIO INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,551 | +34.1% | 1,863 | +93.3% | 0.00% | – |
Q2 2023 | $1,157 | -92.8% | 964 | -92.4% | 0.00% | – |
Q1 2023 | $15,964 | -59.1% | 12,670 | +279.9% | 0.00% | – |
Q3 2022 | $39,000 | +25.8% | 3,335 | -11.8% | 0.00% | – |
Q2 2022 | $31,000 | -48.3% | 3,781 | -45.8% | 0.00% | – |
Q1 2022 | $60,000 | -81.2% | 6,973 | -75.3% | 0.00% | – |
Q4 2021 | $319,000 | +61.1% | 28,214 | +79.8% | 0.00% | – |
Q3 2021 | $198,000 | +57.1% | 15,689 | +1.2% | 0.00% | – |
Q2 2021 | $126,000 | -30.8% | 15,510 | -21.1% | 0.00% | – |
Q1 2021 | $182,000 | -67.5% | 19,669 | -66.1% | 0.00% | – |
Q4 2020 | $560,000 | +12.7% | 57,978 | +44.4% | 0.00% | – |
Q3 2020 | $497,000 | -31.1% | 40,147 | -27.6% | 0.00% | – |
Q2 2020 | $721,000 | +67.7% | 55,415 | +30.7% | 0.00% | – |
Q1 2020 | $430,000 | +13.2% | 42,397 | +74.7% | 0.00% | – |
Q4 2019 | $380,000 | -7.1% | 24,273 | -0.4% | 0.00% | – |
Q3 2019 | $409,000 | -28.0% | 24,365 | -4.7% | 0.00% | – |
Q2 2019 | $568,000 | +350.8% | 25,578 | +341.0% | 0.00% | – |
Q1 2019 | $126,000 | – | 5,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |